{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:20:40Z","timestamp":1764768040628,"version":"3.46.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Retinal vein occlusion (RVO) is a leading cause of vision loss, yet there are inconsistent risk estimates related to risk factors. Mendelian randomization (MR) uses genetic variants as proxies for lifelong exposure and can clarify causal pathways for RVO. We aimed to systematically review MR studies to identify causally supported systemic and ocular risk factors for RVO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Four databases (PubMed, Embase, Scopus, and Web of Science) were searched from inception to June 2025 for peer-reviewed MR studies evaluating modifiable systemic or ocular risk factors in relation to any form of RVO utilizing GWAS data. Narrative synthesis was undertaken as methodological heterogeneity precluded meta-analysis. All effect estimates (ORs) were extracted directly from individual studies and robustness of evidence for each exposure across studies was assessed as robust, probable, suggestive, insufficient, and non-evaluable based on significance and direction of evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twelve two-sample MR studies, all conducted in European cohorts, met inclusion criteria. Ocular traits showed the most consistent signals: higher intraocular pressure (RVO (OR\u2009=\u20091.53, 95% CI: 1.0402.26) and glaucoma liability (OR\u2009=\u20091.31, 95% CI: 1.18\u20131.45) were robustly associated with greater risk of RVO. Among cardiovascular factors, elevated blood pressure\/hypertension liability demonstrated probable evidence of increased RVO risk (OR\u2009=\u20091.58, 95% CI: 1.34\u20131.85), whereas lipid profiles yielded mixed signals, with some support for higher LDL (OR\u2009=\u20091.23, 95% CI: 1.05\u20131.44) and total cholesterol (OR\u2009=\u20091.44, 95% CI: 1.08\u20131.92) effects. For metabolic factors, glycemic traits showed probable to robust evidence with fasting glucose (OR\u2009=\u20095.01, 95% CI: 2.00-12.55) and two-hour glucose (OR\u2009=\u20093.17, 95% CI: 1.63\u20136.18) associated with higher RVO risk. Similarly, type 2 diabetes liability showed probable evidence (OR\u2009=\u20092.82, 95% CI: 2.07\u20133.85); anthropometric measures offered probable to robust support with body mass index (OR\u2009=\u20091.94, 95% CI: 1.23\u20133.08) and waist circumference (OR\u2009=\u20092.40, 95% CI: 1.36\u20134.24) associated with RVO. In other domains, selected coagulation and platelet traits showed probable-robust signals, vitamin D evidence was insufficient, and gut microbiota instruments provided preliminary robust evidence for Bacilli and Family XIII AD3011 association with RVO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Genetic evidence supports a multifactorial vascular-metabolic model for RVO in which elevated IOP, glaucoma, hypertension, adiposity, and acute hyperglycemia are genetically supported risk factors. These findings highlight blood-pressure control, weight management, and glycemic regulation as important prevention targets and underscore the need for ancestry-diverse MR studies with refined phenotyping.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-025-00753-7","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:53:53Z","timestamp":1764766433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling causal pathways in retinal vein occlusion: a systematic review of Mendelian randomization studies"],"prefix":"10.1186","volume":"11","author":[{"given":"Anas","family":"Alamoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Alnabihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz Aiyidh S.","family":"Aljiayyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed K.","family":"Alsarhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan Y.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mihalache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev H.","family":"Muni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel G.","family":"Alakeely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"8","key":"753_CR1","first-page":"981","volume":"25","author":"M Laouri","year":"2011","unstructured":"Laouri M, Chen E, Looman M, Gallagher M. The burden of disease of retinal vein occlusion: review of the literature. Eye Lond Engl. 2011;25(8):981\u20138.","journal-title":"Eye Lond Engl"},{"issue":"1","key":"753_CR2","doi-asserted-by":"publisher","first-page":"010427","DOI":"10.7189\/jogh.09.010427","volume":"9","author":"P Song","year":"2019","unstructured":"Song P, Xu Y, Zha M, Zhang Y, Rudan I. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9(1):010427.","journal-title":"J Glob Health"},{"key":"753_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2147\/OPTH.S7631","volume":"4","author":"N Karia","year":"2010","unstructured":"Karia N. Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol Auckl NZ. 2010;4:809\u201316.","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"753_CR4","doi-asserted-by":"publisher","first-page":"1545602","DOI":"10.3389\/fopht.2025.1545602","volume":"5","author":"X Qiu","year":"2025","unstructured":"Qiu X, Jiao Z, Liu Y, Zhou Y, Li H, Chen X, et al. Risk factors of retinal vein occlusion in East asia: a meta-analysis. Front Ophthalmol. 2025;5:1545602.","journal-title":"Front Ophthalmol"},{"key":"753_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/724780","volume":"2014","author":"P Kolar","year":"2014","unstructured":"Kolar P. Risk factors for central and branch retinal vein occlusion: A Meta-Analysis of published clinical data. J Ophthalmol. 2014;2014:1\u20135.","journal-title":"J Ophthalmol"},{"issue":"1","key":"753_CR6","doi-asserted-by":"publisher","first-page":"100006","DOI":"10.1016\/j.ajoint.2024.100006","volume":"1","author":"D Kazantzis","year":"2024","unstructured":"Kazantzis D, Machairoudia G, Dimitriou E, Kroupis C, Theodossiadis G, Theodossiadis P, et al. Risk factors for retinal vein occlusion: multivariate approach in a case-control study. AJO Int. 2024;1(1):100006.","journal-title":"AJO Int"},{"issue":"6","key":"753_CR7","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1097\/PRS.0b013e3181f44abc","volume":"126","author":"JW Song","year":"2010","unstructured":"Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg. 2010;126(6):2234\u201342.","journal-title":"Plast Reconstr Surg"},{"key":"753_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mam.2019.01.002","volume":"69","author":"AJ Cornish","year":"2019","unstructured":"Cornish AJ, Tomlinson IPM, Houlston RS. Mendelian randomisation: A powerful and inexpensive method for identifying and excluding non-genetic risk factors for colorectal cancer. Mol Aspects Med. 2019;69:41\u20137.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"753_CR9","doi-asserted-by":"publisher","first-page":"a040501","DOI":"10.1101\/cshperspect.a040501","volume":"12","author":"RC Richmond","year":"2022","unstructured":"Richmond RC, Davey Smith G. Mendelian randomization: concepts and scope. Cold Spring Harb Perspect Med. 2022;12(1):a040501.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"753_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40246-024-00637-1","volume":"18","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yuan W, Xu J, Zhao F. Application of Mendelian randomization in ocular diseases: a review. Hum Genomics. 2024;18(1):66.","journal-title":"Hum Genomics"},{"issue":"4","key":"753_CR11","doi-asserted-by":"publisher","first-page":"e209128","DOI":"10.1212\/WNL.0000000000209128","volume":"102","author":"E Gagnon","year":"2024","unstructured":"Gagnon E, Daghlas I, Zagkos L, Sargurupremraj M, Georgakis MK, Anderson CD, et al. Mendelian randomization applied to neurology: promises and challenges. Neurology. 2024;102(4):e209128.","journal-title":"Neurology"},{"key":"753_CR12","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, LI T, Page M, et al. Cochrane Handbook for Systematic Reviews of Interventions (updated August 2023). version 6.4. 2023. Available from: https:\/\/www.training.cochrane.org\/handbook."},{"key":"753_CR13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"1","key":"753_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"issue":"16","key":"753_CR15","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326(16):1614.","journal-title":"JAMA"},{"issue":"1","key":"753_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12916-022-02246-y","volume":"20","author":"G Markozannes","year":"2022","unstructured":"Markozannes G, Kanellopoulou A, Dimopoulou O, Kosmidis D, Zhang X, Wang L, et al. Systematic review of Mendelian randomization studies on risk of cancer. BMC Med. 2022;20(1):41.","journal-title":"BMC Med"},{"issue":"4","key":"753_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/gepi.22295","volume":"44","author":"EAW Slob","year":"2020","unstructured":"Slob EAW, Burgess S. A comparison of robust Mendelian randomization methods using summary data. Genet Epidemiol. 2020;44(4):313\u201329.","journal-title":"Genet Epidemiol"},{"key":"753_CR18","doi-asserted-by":"publisher","first-page":"954453","DOI":"10.3389\/fendo.2022.954453","volume":"13","author":"C Zheng","year":"2022","unstructured":"Zheng C, Lin Y, Jiang B, Zhu X, Lin Q, Luo W, et al. Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization. Front Endocrinol. 2022;13:954453.","journal-title":"Front Endocrinol"},{"key":"753_CR19","doi-asserted-by":"publisher","first-page":"1146185","DOI":"10.3389\/fendo.2023.1146185","volume":"14","author":"J Huang","year":"2023","unstructured":"Huang J. Mendelian randomization indicates a causal contribution of type 2 diabetes to retinal vein occlusion. Front Endocrinol. 2023;14:1146185.","journal-title":"Front Endocrinol"},{"key":"753_CR20","doi-asserted-by":"crossref","unstructured":"Fan S, Shi Xyu, Li X, Li J, Yu SP. Vitamin D levels and risk of ocular disorders: insights from bidirectional and multivariable Mendelian randomization analysis. Front Med. 2024;11:1431170.","DOI":"10.3389\/fmed.2024.1431170"},{"issue":"1","key":"753_CR21","doi-asserted-by":"publisher","first-page":"9593","DOI":"10.1038\/s41467-024-52334-1","volume":"15","author":"S Ort\u00edn Vela","year":"2024","unstructured":"Ort\u00edn Vela S, Beyeler MJ, Trofimova O, Iuliani I, Vargas Quiros JD, De Vries VA, et al. Phenotypic and genetic characteristics of retinal vascular parameters and their association with diseases. Nat Commun. 2024;15(1):9593.","journal-title":"Nat Commun"},{"issue":"17","key":"753_CR22","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1038\/s41433-024-03303-x","volume":"38","author":"A Katsimpris","year":"2024","unstructured":"Katsimpris A, Baumeister SE, Voulgari N, Baurecht H, Kandarakis S, Nolde M. Intraocular pressure, primary open-angle glaucoma and the risk of retinal vein occlusion: A Mendelian randomization mediation analysis. Eye. 2024;38(17):3347\u201351.","journal-title":"Eye"},{"issue":"12","key":"753_CR23","doi-asserted-by":"publisher","first-page":"030006052412869","DOI":"10.1177\/03000605241286985","volume":"52","author":"Z Wang","year":"2024","unstructured":"Wang Z, Xu K, Zhang X, Wei R, Li Z. Causal association between glaucoma and risk of retinal vascular occlusion: a Mendelian randomization study. J Int Med Res. 2024;52(12):03000605241286985.","journal-title":"J Int Med Res"},{"issue":"18","key":"753_CR24","doi-asserted-by":"publisher","first-page":"e41752","DOI":"10.1097\/MD.0000000000041752","volume":"104","author":"B Jiang","year":"2025","unstructured":"Jiang B, Wei X, Cao X, Zheng C. Insights into modifiable risk factors of retinal vascular occlusion: A Mendelian randomization study. Med (Baltim). 2025;104(18):e41752.","journal-title":"Med (Baltim)"},{"issue":"1","key":"753_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.14.1.5","volume":"14","author":"S Lei","year":"2025","unstructured":"Lei S, Liu Y. Identifying the involvement of gut microbiota in retinal vein occlusion by Mendelian randomization and genetic correlation analysis. Transl Vis Sci Technol. 2025;14(1):5.","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"753_CR26","doi-asserted-by":"publisher","first-page":"18659","DOI":"10.1038\/s41598-025-02874-3","volume":"15","author":"Y Nie","year":"2025","unstructured":"Nie Y, Zhang X, Wu X, Mi Q, Yang Z, Duan J. Causal relationship between glycemic traits and inflammatory eye diseases and their complications, and myopia: a Mendelian randomization analysis. Sci Rep. 2025;15(1):18659.","journal-title":"Sci Rep"},{"issue":"1","key":"753_CR27","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1038\/s41598-025-87648-7","volume":"15","author":"C Yuan","year":"2025","unstructured":"Yuan C, He C, Zuo L, Liu B, Qi H. The effect of coagulation traits on the risk of retinal vein occlusion: a Mendelian randomization study. Sci Rep. 2025;15(1):3052.","journal-title":"Sci Rep"},{"key":"753_CR28","doi-asserted-by":"crossref","unstructured":"Yuan W, Xu X, Zhang X, Fan W, Zhou W, Zhao F. Exploring the associations of obesity and glycemic traits with retinal vein occlusion: a univariate and multivariable Mendelian randomization study. Ophthalmic Epidemiol. 2025;1\u20139.","DOI":"10.1080\/09286586.2025.2458245"},{"issue":"4","key":"753_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/ahg.12552","volume":"88","author":"J Zhang","year":"2024","unstructured":"Zhang J, Pan Y, Yang H, Hu S, Zheng S, He T. Genetically predicted retinal vascular occlusion in relation to cardiovascular diseases: A bidirectional two-sample Mendelian randomization analysis. Ann Hum Genet. 2024;88(4):336\u201348.","journal-title":"Ann Hum Genet"},{"issue":"7","key":"753_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/aos.14141","volume":"97","author":"X Yin","year":"2019","unstructured":"Yin X, Li J, Zhang B, Lu P. Association of glaucoma with risk of retinal vein occlusion: A meta-analysis. Acta Ophthalmol (Copenh). 2019;97(7):652\u20139.","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"753_CR31","doi-asserted-by":"publisher","first-page":"108607","DOI":"10.1016\/j.diabres.2020.108607","volume":"171","author":"YS Chang","year":"2021","unstructured":"Chang YS, Ho CH, Chu CC, Wang JJ, Jan RL. Risk of retinal vein occlusion in patients with diabetes mellitus: A retrospective cohort study. Diabetes Res Clin Pract. 2021;171:108607.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"753_CR32","doi-asserted-by":"publisher","first-page":"100734","DOI":"10.1016\/j.xops.2025.100734","volume":"5","author":"SY Pan","year":"2025","unstructured":"Pan SY, Weng CH, Tsai SF, Sheen YJ, Lin HJ, Tien PT, et al. Risk of retinal vein occlusion between Glucagon-Like Peptide-1 receptor agonists and dipeptidyl Peptidase-4 inhibitors in type 2 diabetes: A retrospective cohort study. Ophthalmol Sci. 2025;5(4):100734.","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"753_CR33","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.1038\/s41598-020-67375-x","volume":"10","author":"DW Paik","year":"2020","unstructured":"Paik DW, Han K, Kang SW, Ham DI, Kim SJ, Chung TY, et al. Differential effect of obesity on the incidence of retinal vein occlusion with and without diabetes: a Korean nationwide cohort study. Sci Rep. 2020;10(1):10512.","journal-title":"Sci Rep"},{"issue":"02","key":"753_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1160\/TH09-05-0331","volume":"103","author":"C Kuhli-Hattenbach","year":"2010","unstructured":"Kuhli-Hattenbach C, Scharrer I, L\u00fcchtenberg M, Hattenbach LO. Coagulation disorders and the risk of retinal vein occlusion: A subgroup analysis. Thromb Haemost. 2010;103(02):299\u2013305.","journal-title":"Thromb Haemost"},{"issue":"8","key":"753_CR35","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.4103\/jfmpc.jfmpc_1885_23","volume":"13","author":"PK Sahu","year":"2024","unstructured":"Sahu PK, Gautam P, Das GK, Gogoi P, Beri N, Bhatia R. Emerging role of vitamin D deficiency as a risk factor for retinal venous occlusions and need for public health measures for its prevention. J Fam Med Prim Care. 2024;13(8):3298\u2013303.","journal-title":"J Fam Med Prim Care"},{"issue":"2","key":"753_CR36","first-page":"182","volume":"8","author":"R Daneshvar","year":"2013","unstructured":"Daneshvar R. Anti-VEGF agents and glaucoma filtering surgery. J Ophthalmic Vis Res. 2013;8(2):182\u20136.","journal-title":"J Ophthalmic Vis Res"},{"issue":"8","key":"753_CR37","doi-asserted-by":"publisher","first-page":"e0005224","DOI":"10.1128\/spectrum.00052-24","volume":"12","author":"J Ai","year":"2024","unstructured":"Ai J, Cao Y, Zhang C, Sun JH, Dong F, Jing L, et al. Deciphering the interplay of gut microbiota and metabolomics in retinal vein occlusion. Microbiol Spectr. 2024;12(8):e0005224.","journal-title":"Microbiol Spectr"},{"issue":"11","key":"753_CR38","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.ajpath.2023.02.017","volume":"193","author":"JB Lincke","year":"2023","unstructured":"Lincke JB, Christe L, Unterlauft JD, Zinkernagel MS, Zysset-Burri DC. Microbiome and retinal vascular diseases. Am J Pathol. 2023;193(11):1675\u201382.","journal-title":"Am J Pathol"},{"key":"753_CR39","doi-asserted-by":"crossref","unstructured":"Lu Y, Hua Y, Wang B, Tian Q, Zhong F, Theophanous A, et al. Impact of elevated intraocular pressure on lamina cribrosa oxygenation: a combined experimental-computational study on monkeys. Ophthalmol Sci. 2025;5(3):100725.","DOI":"10.1016\/j.xops.2025.100725"},{"key":"753_CR40","doi-asserted-by":"crossref","unstructured":"Varghese M, Adhyapak SM, Thomas T, Sunder M, Varghese K. The association of severity of retinal vascular changes and cardiac remodelling in systemic hypertension. Ther Adv Cardiovasc Dis. 2016;10(4):224\u201330.","DOI":"10.1177\/1753944716630869"},{"key":"753_CR41","doi-asserted-by":"crossref","unstructured":"Pomero F, Di Minno MND, Fenoglio L, Gianni M, Ageno W, Dentali F. Is diabetes a hypercoagulable state? A critical appraisal. Acta Diabetol. 2015;52(6):1007\u201316.","DOI":"10.1007\/s00592-015-0746-8"},{"key":"753_CR42","doi-asserted-by":"crossref","unstructured":"Tauqeer Z, Bracha P, McGeehan B, VanderBeek BL. Hypercoagulability testing and hypercoagulable disorders in young central retinal vein occlusion patients. Ophthalmol Retina. 2022;6(1):37\u201342.","DOI":"10.1016\/j.oret.2021.03.009"},{"key":"753_CR43","doi-asserted-by":"crossref","unstructured":"Garnavou-Xirou C, Bontzos G, Smoustopoulos G, Velissaris S, Papadopoulos A, Georgopoulos E, et al. Systemic risk factors in branch retinal vein occlusion: a comprehensive review. Maedica. 2024;19(2):380\u20137.","DOI":"10.26574\/maedica.2024.19.2.380"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00753-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:53:57Z","timestamp":1764766437000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00753-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00753-7","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Anas Alamoudi: None. Ahmed Alnabihi: None. Sultan Al-Qahtani: None. Abdulaziz Aiyidh S. Aljiayyd: None. Waleed K. Alsarhani: None. Suzan Y. Alharbi: None. Andrew Mihalache: None. Marko Popovic: Financial Support to Institution: PSI Foundation, Fighting Blindness Canada, consultant - AInnova Technologies. Rajeev H. Muni: Consultant \u2013 Alcon, Apellis, AbbVie, Bayer, Bausch Health, Roche; Financial Support (to institution) \u2013 Alcon, AbbVie, Bayer, Novartis, Roche. Adel G Alakeely: None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}